Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,121,500
-
Total 13F shares
-
28,210,083
-
Share change
-
+16,466,303
-
Total reported value
-
$84,630,390
-
Price per share
-
$3.00
-
Number of holders
-
28
-
Value change
-
+$49,505,803
-
Number of buys
-
13
-
Number of sells
-
16
Institutional Holders of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) as of Q3 2025
As of 30 Sep 2025,
Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,210,083 shares.
The largest 10 holders included
5AM Venture Management, LLC, JANUS HENDERSON GROUP PLC, Vivo Capital, LLC, ENAVATE SCIENCES GP, LLC, FMR LLC, a16z Capital Management, L.L.C., ADAGE CAPITAL PARTNERS GP, L.L.C., HarbourVest Partners LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and VANGUARD GROUP INC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.